-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Evolutionary Genomics, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2021 to 2022.
- Evolutionary Genomics, Inc. Earnings Per Share, Diluted for the quarter ending December 31, 2022 was -0.07 USD/shares, a 41.7% increase year-over-year.
- Evolutionary Genomics, Inc. Earnings Per Share, Diluted for the twelve months ending December 31, 2022 was -0.35 USD/shares, a 32.7% increase year-over-year.
- Evolutionary Genomics, Inc. annual Earnings Per Share, Diluted for 2022 was -0.35 USD/shares, a 32.7% increase from 2021.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)